SCAI 2021

Follow-up Results for Harmony TPV System Demonstrate Efficacy at 1-Year

May 02, 2021

Results of 1-year follow-up from the Harmony TPV Clinical trial provide insight into the safety and efficacy of the recently approved Harmony TPV system in patients with congenital heart disease and severe pulmonary regurgitation.

Presentations for Acute MIs Dropped Drastically During Peak of COVID-19 Pandemic

April 30, 2021

An analysis of data from NYU Langone provides perspective into the rapid decline of emergency department presentations for acute myocardial infarction that occurred during the peak of the COVID-19 pandemic.

SCAI 2021: ISCHEMIA Represents a Fraction of Patients with SIHD Undergoing PCI

April 29, 2021

An analysis comparing a national registry against ISCHEMIA enrollment criteria suggests trial eligibility represents less than 2% of all patients undergoing PCI and less than a third of patients undergoing PCI with stable ischemic heart disease.

Extended-Duration DAPT Reduces Mortality, Event Rate in TWILIGHT-like Patients

April 29, 2021

An SCAI 2021 analysis of more than 4k patients with characteristics similar to those included in the TWILIGHT trial indicates extended-duration DAPT, defined as a duration of more than 12 months post-PCI, was a more efficacious approach than short-term DAPT in this patient population.